tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSE:MSCL Stock Latest News

Satellos Bioscience to Court Investors as Phase 2 DMD Program Advances
Company AnnouncementsSatellos Bioscience to Court Investors as Phase 2 DMD Program Advances
4d ago
6K
MSLE
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy
PremiumCompany Announcements
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy
5d ago
6K
MSLE
Satellos to Highlight Duchenne Drug Program at Series of Investor Conferences
PremiumCompany Announcements
Satellos to Highlight Duchenne Drug Program at Series of Investor Conferences
6d ago
MSLE
Satellos Bioscience Doses First Patient in Phase 2 Pediatric Duchenne Study of SAT-3247
PremiumCompany Announcements
Satellos Bioscience Doses First Patient in Phase 2 Pediatric Duchenne Study of SAT-3247
12d ago
6K
MSLE
Satellos price target raised to $40 from $5 at Oppenheimer
PremiumThe Fly
Satellos price target raised to $40 from $5 at Oppenheimer
14d ago
MSLE
Satellos Bioscience to Highlight Muscle-Regeneration Platform at Guggenheim Biotech Summit 2026
PremiumCompany AnnouncementsSatellos Bioscience to Highlight Muscle-Regeneration Platform at Guggenheim Biotech Summit 2026
14d ago
6K
MSLE
Satellos Bioscience Raises US$57.2 Million in Cross-Border Equity Offering to Advance Muscle Disease Pipeline
Premium
Company Announcements
Satellos Bioscience Raises US$57.2 Million in Cross-Border Equity Offering to Advance Muscle Disease Pipeline
14d ago
6K
Satellos Raises US$50 Million in Cross-Border Offering as Shares Debut on Nasdaq
Premium
Company Announcements
Satellos Raises US$50 Million in Cross-Border Offering as Shares Debut on Nasdaq
17d ago
Satellos Plans Cross-Border Share Offering and Nasdaq Listing to Fund Muscle Disease Pipeline
PremiumCompany Announcements
Satellos Plans Cross-Border Share Offering and Nasdaq Listing to Fund Muscle Disease Pipeline
18d ago
Satellos Strengthens Executive Bench With Veteran Regulator as Duchenne Program Advances
PremiumCompany Announcements
Satellos Strengthens Executive Bench With Veteran Regulator as Duchenne Program Advances
25d ago
Satellos Bioscience appoints Antoinette Paone as chief development officer
PremiumThe Fly
Satellos Bioscience appoints Antoinette Paone as chief development officer
26d ago
GBIO
Satellos Consolidates Shares Ahead of Proposed Nasdaq Listing
PremiumCompany Announcements
Satellos Consolidates Shares Ahead of Proposed Nasdaq Listing
26d ago
Satellos Bioscience to Present at December Investor Conferences
PremiumCompany AnnouncementsSatellos Bioscience to Present at December Investor Conferences
3M ago
Buy Rating for Satellos Bioscience Driven by Promising Clinical Developments and Strong Financial Outlook
Premium
Ratings
Buy Rating for Satellos Bioscience Driven by Promising Clinical Developments and Strong Financial Outlook
3M ago
Satellos Bioscience Unveils Groundbreaking Research in Duchenne Muscular Dystrophy Treatment
Premium
Company Announcements
Satellos Bioscience Unveils Groundbreaking Research in Duchenne Muscular Dystrophy Treatment
3M ago
Satellos Bioscience Strengthens Leadership and Advances Clinical Trials for DMD Treatment
PremiumCompany Announcements
Satellos Bioscience Strengthens Leadership and Advances Clinical Trials for DMD Treatment
3M ago
Satellos Bioscience to Present at November Investor Conferences
PremiumCompany Announcements
Satellos Bioscience to Present at November Investor Conferences
4M ago
Satellos Bioscience Advances Duchenne Treatment with New Study
PremiumCompany Announcements
Satellos Bioscience Advances Duchenne Treatment with New Study
4M ago
Satellos Bioscience Reports Positive Phase 1 Trial Results for Duchenne Muscular Dystrophy Treatment
PremiumCompany Announcements
Satellos Bioscience Reports Positive Phase 1 Trial Results for Duchenne Muscular Dystrophy Treatment
5M ago
Satellos Bioscience announces data on tolerability, initial efficacy of SAT-3247
PremiumThe FlySatellos Bioscience announces data on tolerability, initial efficacy of SAT-3247
5M ago
Satellos Bioscience to Present Key Findings on Duchenne Treatment at World Muscle Society Congress
Premium
Company Announcements
Satellos Bioscience to Present Key Findings on Duchenne Treatment at World Muscle Society Congress
5M ago
Satellos Bioscience Advances Phase 2 Trial for Duchenne Muscular Dystrophy Treatment
Premium
Company Announcements
Satellos Bioscience Advances Phase 2 Trial for Duchenne Muscular Dystrophy Treatment
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >